News
CarMax Reports Downbeat Earnings, Joins Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
11 Apr 24
News, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Nanobiotix Announces Completion Of Phase 1 Dose Escalation And NBTXR3 Recommended Phase 2 Dose For The Treatment Of Inoperable, Recurrent Lung Cancer In Patients Amenable To Re-Irradiation
2 Apr 24
Biotech, News, General
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
18 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
18 Mar 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
11 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
11 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
General Motors Posts Upbeat Earnings, Joins Corning, HCA Healthcare And Other Big Stocks Moving Higher On Tuesday
30 Jan 24
News, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Nanobiotix Reports Achievement Of $20M Development Milestone Payment Regarding Ongoing Global Phase 3 Head And Neck Cancer Study
29 Jan 24
News
Press releases
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
17 Apr 24
Press Releases
Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation
2 Apr 24
Health Care, Press Releases
Nanobiotix to Present at Upcoming Investor Conferences in March
6 Mar 24
News, Press Releases
Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference
31 Jan 24
Press Releases
Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study
29 Jan 24
News, Health Care, Financing, Contracts, Press Releases